Streetbeat News

Revenues

CRNC

Analyst ratings for Cerence (NASDAQ:CRNC) show a mix of bullish and bearish perspectives with a significant decrease in the average 12-month price target from $20.00 to $11.58. Recent actions by analysts include lowering price targets and maintaining ratings, reflecting a cautious outlook on the company's performance despite its strong financial health indicators such as a 65.36% revenue growth rate and a net margin of 17.25%.

Portfolio Pulse from Benzinga Insights

May 10, 2024 | 5:00 pm

SQSP

Mizuho analyst Siti Panigrahi upgraded Squarespace (NYSE:SQSP) to Buy from Neutral, with a price target increase to $50 from $34, citing potential for significant growth driven by Google Domains acquisition, pricing tailwinds, and Squarespace Payments. The company is expected to see 20%+ growth with 30% uFCF margins over the medium term. The Google Domains acquisition has already contributed $13 million in revenue, with expectations of substantial revenue contributions from domains and pricing increases in the coming years.

Portfolio Pulse from Nabaparna Bhattacharya

May 10, 2024 | 4:35 pm

CBAT

CBAK Energy Technology, Inc. (NASDAQ:CBAT) reported first-quarter FY24 results with a 38.7% Y/Y revenue increase to $58.82 million, missing consensus estimates. The battery business saw a 51.5% Y/Y growth, notably in residential energy supply, despite a decline in light electric vehicle batteries. Gross profit soared to $18.8 million, with a gross margin increase to 31.9%. Net income reached $9.8 million, turning around from a net loss the previous year, with an EPS of $0.11 beating consensus. The company anticipates further growth and profitability in its battery business for the rest of the year.

Portfolio Pulse from Lekha Gupta

May 10, 2024 | 4:15 pm

OPRT

Oportun Financial's shares surged following the announcement of their Q1 financial results, which exceeded expectations. Additionally, the company provided Q2 revenue guidance with its midpoint surpassing estimates.

Portfolio Pulse from Benzinga Newsdesk

May 10, 2024 | 4:07 pm

AMPL

Amplitude (NASDAQ:AMPL) received mixed analyst ratings with a downward trend in price targets, indicating a cautious outlook. The average 12-month price target is now $10.75, down 10.42% from $12.00. Analysts from Morgan Stanley, Citigroup, and Piper Sandler adjusted their ratings and price targets, reflecting changing market conditions and Amplitude's performance. Despite a positive revenue growth rate of 9.42% for the last quarter, Amplitude's financials show mixed results, with a high net margin of -25.97% but a low ROA of -4.24%.

Portfolio Pulse from Benzinga Insights

May 10, 2024 | 4:01 pm

GLOB

Analysts have provided diverse opinions on Globant (NYSE:GLOB) with 13 ratings ranging from bullish to bearish over the past quarter. The average 12-month price target for Globant is now $252.15, down 3.58% from the previous $261.50. Analyst actions include adjustments to ratings and price targets, reflecting changing market conditions and company performance. Globant's financial performance is strong, with notable revenue growth, net margin, ROE, and ROA, all surpassing industry averages.

Portfolio Pulse from Benzinga Insights

May 10, 2024 | 4:01 pm

AFRM

Affirm Holdings (NASDAQ:AFRM) has been the subject of varied analyst ratings over the past three months, with recent updates showing a mix of lowered and raised price targets and ratings. The average 12-month price target for AFRM now stands at $44.0, down from $46.60, reflecting a decrease of 5.58%. Analysts' actions, including both downgrades and upgrades, indicate a nuanced view of the company's future performance. Despite a positive revenue trend with a growth rate of 51.23%, concerns about profitability, debt management, and below-average market capitalization are highlighted.

Portfolio Pulse from Benzinga Insights

May 10, 2024 | 4:00 pm

GETY

Getty Images Holdings (NYSE:GETY) has received mixed analyst evaluations over the last three months, with recent ratings ranging from bullish to bearish. The average 12-month price target for GETY is now $7.08, reflecting a 3.66% increase from the previous target of $6.83. Analyst actions include both upgrades and downgrades, with price targets ranging from $6.00 to $8.00. Despite a negative revenue trend and a high debt-to-equity ratio, GETY exhibits strong profitability indicators such as a net margin of 17.31%, ROE of 6.56%, and ROA of 1.53%.

Portfolio Pulse from Benzinga Insights

May 10, 2024 | 4:00 pm

FIGS

Recent analyst ratings for FIGS (NYSE:FIGS) show a mix of bullish and bearish perspectives, with a total of 9 analysts providing ratings in the past three months. The average 12-month price target for FIGS is now $6.04, down from $7.20, indicating a 16.11% decrease. Analyst actions include lowering price targets and maintaining or lowering ratings, reflecting changes in market conditions and company performance. FIGS Inc, a healthcare apparel company, has shown positive revenue growth and strong profitability but faces challenges in ROE.

Portfolio Pulse from Benzinga Insights

May 10, 2024 | 4:00 pm

FXI

NVDA

SPY

TSM

The article discusses aggressive stock buying amid rising layoffs and a revenue increase at TSMC. It highlights the SPDR S&P 500 ETF Trust's (SPY) performance, jobless claims, TSMC's booming sales, and the impact on AI stocks like NVIDIA (NVDA), AMD, Micron Technology (MU), and Applied Materials (AMAT). It also mentions China's market attractiveness, represented by the iShares China Large-Cap ETF (FXI), and the positive early trade money flows in major tech stocks and ETFs like QQQ, with a note on gold, oil, and Bitcoin movements.

Portfolio Pulse from The Arora Report

May 10, 2024 | 3:50 pm